198 related articles for article (PubMed ID: 18400759)
1. Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice.
Orr AL; Huang S; Roberts MA; Reed JC; Li S; Li XJ
J Biol Chem; 2008 Jun; 283(23):16027-36. PubMed ID: 18400759
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.
Bradford J; Shin JY; Roberts M; Wang CE; Sheng G; Li S; Li XJ
J Biol Chem; 2010 Apr; 285(14):10653-61. PubMed ID: 20145253
[TBL] [Abstract][Full Text] [Related]
3. The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes.
Tagawa K; Marubuchi S; Qi ML; Enokido Y; Tamura T; Inagaki R; Murata M; Kanazawa I; Wanker EE; Okazawa H
J Neurosci; 2007 Jan; 27(4):868-80. PubMed ID: 17251428
[TBL] [Abstract][Full Text] [Related]
4. BAG1 modulates huntingtin toxicity, aggregation, degradation, and subcellular distribution.
Sroka K; Voigt A; Deeg S; Reed JC; Schulz JB; Bähr M; Kermer P
J Neurochem; 2009 Nov; 111(3):801-7. PubMed ID: 19712056
[TBL] [Abstract][Full Text] [Related]
5. Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice.
Wang CE; Li S; Li XJ
Mol Brain; 2010 Nov; 3():33. PubMed ID: 21044321
[TBL] [Abstract][Full Text] [Related]
6. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.
Chan EY; Luthi-Carter R; Strand A; Solano SM; Hanson SA; DeJohn MM; Kooperberg C; Chase KO; DiFiglia M; Young AB; Leavitt BR; Cha JH; Aronin N; Hayden MR; Olson JM
Hum Mol Genet; 2002 Aug; 11(17):1939-51. PubMed ID: 12165556
[TBL] [Abstract][Full Text] [Related]
7. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
[TBL] [Abstract][Full Text] [Related]
8. Experimental mutagenesis of huntingtin to map cleavage sites: different outcomes in cell and mouse models.
Tebbenkamp AT; Xu G; Siemienski ZB; Janus C; Fromholt SE; Brown HH; Swing D; Tessarollo L; Borchelt DR
J Huntingtons Dis; 2014; 3(1):73-86. PubMed ID: 25062766
[TBL] [Abstract][Full Text] [Related]
9. Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin.
Chafekar SM; Duennwald ML
PLoS One; 2012; 7(5):e37929. PubMed ID: 22649566
[TBL] [Abstract][Full Text] [Related]
10. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models.
Schilling G; Klevytska A; Tebbenkamp AT; Juenemann K; Cooper J; Gonzales V; Slunt H; Poirer M; Ross CA; Borchelt DR
J Neuropathol Exp Neurol; 2007 Apr; 66(4):313-20. PubMed ID: 17413322
[TBL] [Abstract][Full Text] [Related]
11. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
Jana NR; Tanaka M; Wang Gh; Nukina N
Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
[TBL] [Abstract][Full Text] [Related]
12. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.
Schilling G; Savonenko AV; Klevytska A; Morton JL; Tucker SM; Poirier M; Gale A; Chan N; Gonzales V; Slunt HH; Coonfield ML; Jenkins NA; Copeland NG; Ross CA; Borchelt DR
Hum Mol Genet; 2004 Aug; 13(15):1599-610. PubMed ID: 15190011
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.
Tebbenkamp AT; Green C; Xu G; Denovan-Wright EM; Rising AC; Fromholt SE; Brown HH; Swing D; Mandel RJ; Tessarollo L; Borchelt DR
Hum Mol Genet; 2011 Jul; 20(14):2770-82. PubMed ID: 21515588
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.
Mughal MR; Baharani A; Chigurupati S; Son TG; Chen E; Yang P; Okun E; Arumugam T; Chan SL; Mattson MP
Hum Mol Genet; 2011 Feb; 20(4):659-69. PubMed ID: 21106706
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.
Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W
J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812
[TBL] [Abstract][Full Text] [Related]
18. Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease.
Klevytska AM; Tebbenkamp AT; Savonenko AV; Borchelt DR
J Neuropathol Exp Neurol; 2010 Apr; 69(4):396-404. PubMed ID: 20448484
[TBL] [Abstract][Full Text] [Related]
19. Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.
O'Brien R; DeGiacomo F; Holcomb J; Bonner A; Ring KL; Zhang N; Zafar K; Weiss A; Lager B; Schilling B; Gibson BW; Chen S; Kwak S; Ellerby LM
J Biol Chem; 2015 Jul; 290(31):19287-306. PubMed ID: 26025364
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.
Perrin V; Régulier E; Abbas-Terki T; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Mol Ther; 2007 May; 15(5):903-11. PubMed ID: 17375066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
